Lentini Renee's most recent trade in Immunogen, Inc. was a trade of 467 Common Stock done at an average price of $16.0 . Disclosure was reported to the exchange on Dec. 29, 2023.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Immunogen, Inc. | Lentini Renee | VP & PRIN ACCTG OFFICER | Grant, award, or other acquisition of securities at price $ 16.01 per share. | 29 Dec 2023 | 467 | 8,919 (0%) | 0% | 16.0 | 7,477 | Common Stock |
| Immunogen, Inc. | Renee Lentini | VP & PRIN ACCTG OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 15,000 | 15,000 (0%) | 0% | 0 | Common Stock | |
| Immunogen, Inc. | Renee Lentini | VP & PRIN ACCTG OFFICER | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Dec 2023 | 15,000 | 22,500 | - | - | Restricted Stock Unit | |
| Immunogen, Inc. | Lentini Renee | VP & PRIN ACCTG OFFICER | Sale of securities on an exchange or to another person at price $ 29.74 per share. | 22 Dec 2023 | 6,548 | 8,452 (0%) | 0% | 29.7 | 194,738 | Common Stock |
| Immunogen, Inc. | Renee Lentini | V.P.-FIN., PRIN. ACCTG. OFF. | Grant, award, or other acquisition of securities at price $ 4.05 per share. | 30 Jun 2023 | 3,195 | 22,843 (0%) | 0% | 4.1 | 12,940 | Common Stock |
| Immunogen, Inc. | Renee Lentini | V.P.-FIN., PRIN. ACCTG. OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 50,610 | 50,610 | - | - | Stock Option (right to buy) | |
| Immunogen, Inc. | Renee Lentini | V.P.-FIN., PRIN. ACCTG. OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2023 | 25,305 | 25,305 | - | - | Restricted Stock Unit | |
| Immunogen, Inc. | Renee Lentini | V.P.-FIN., PRIN. ACCTG. OFF. | Grant, award, or other acquisition of securities at price $ 3.92 per share. | 30 Dec 2022 | 1,351 | 19,648 (0%) | 0% | 3.9 | 5,296 | Common Stock |
| Immunogen, Inc. | Renee Lentini | V.P.-FIN., PRIN. ACCTG. OFF. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 22 Dec 2022 | 37,500 | 37,500 | - | - | Restricted Stock Unit | |
| Immunogen, Inc. | Renee Lentini | V.P.-FIN., PRIN. ACCTG. OFF. | Grant, award, or other acquisition of securities at price $ 3.83 per share. | 30 Jun 2022 | 2,509 | 18,297 (0%) | 0% | 3.8 | 9,597 | Common Stock |
| Immunogen, Inc. | Renee Lentini | V.P.-Fin., Prin. Acctg. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 04 Feb 2022 | 95,700 | 95,700 | - | - | Common Stock (right to buy) | |
| Immunogen, Inc. | Renee Lentini | V.P.-Fin., Prin. Acctg. Off. | Grant, award, or other acquisition of securities at price $ 5.52 per share. | 30 Jun 2021 | 1,683 | 13,831 (0%) | 0% | 5.5 | 9,290 | Common Stock |
| Immunogen, Inc. | Renee Lentini | V.P.-Fin., Prin. Acctg. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Feb 2021 | 80,800 | 80,800 | - | - | Common Stock (right to buy) | |
| Immunogen, Inc. | Renee Lentini | V.P.-Fin., Prin. Acctg. Off. | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Jan 2021 | 40,400 | 40,400 | - | - | Stock Option (right to buy) |